Mg OSTEOCRETE Post-Treatment Outcomes

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Cancer of BoneTraumaAseptic Loosening of Orthopaedic Hardware
Interventions
DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by bone tumor resection

DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by aseptic loosening of orthopaedic hardware

DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by trauma-related conditions

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alliant Biotech, LLC

UNKNOWN

lead

Santiago Lozano-Calderon

OTHER

NCT06720142 - Mg OSTEOCRETE Post-Treatment Outcomes | Biotech Hunter | Biotech Hunter